Jefferies Group LLC reaffirmed their buy rating on shares of Organovo Holdings, Inc. (NASDAQ:ONVO) in a research note issued to investors on Thursday. The brokerage currently has a $4.00 price objective on the stock.

Several other research firms have also recently weighed in on ONVO. Evercore ISI restated an outperform rating and set a $3.75 price target (down previously from $4.00) on shares of Organovo Holdings in a report on Friday, June 9th. BidaskClub cut Organovo Holdings from a sell rating to a strong sell rating in a report on Tuesday, July 25th. Finally, Zacks Investment Research upgraded Organovo Holdings from a sell rating to a hold rating in a report on Wednesday, April 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of Buy and an average target price of $6.20.

Shares of Organovo Holdings (NASDAQ:ONVO) traded down 0.4316% during mid-day trading on Thursday, reaching $2.3299. The company’s stock had a trading volume of 271,127 shares. Organovo Holdings has a 12-month low of $2.29 and a 12-month high of $4.99. The company’s 50-day moving average price is $2.59 and its 200-day moving average price is $2.95.

Organovo Holdings (NASDAQ:ONVO) last issued its earnings results on Wednesday, June 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. The company had revenue of $0.80 million for the quarter, compared to the consensus estimate of $0.76 million. Organovo Holdings had a negative return on equity of 63.92% and a negative net margin of 908.91%. The business’s revenue for the quarter was up 700.0% compared to the same quarter last year. Equities analysts predict that Organovo Holdings will post ($0.39) EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Organovo Holdings’ (ONVO) Buy Rating Reaffirmed at Jefferies Group LLC” was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/organovo-holdings-onvo-buy-rating-reaffirmed-at-jefferies-group-llc/1464202.html.

A number of institutional investors have recently added to or reduced their stakes in ONVO. Schwab Charles Investment Management Inc. boosted its position in Organovo Holdings by 32.8% in the first quarter. Schwab Charles Investment Management Inc. now owns 385,659 shares of the company’s stock valued at $1,227,000 after buying an additional 95,177 shares in the last quarter. KCG Holdings Inc. boosted its position in Organovo Holdings by 139.3% in the first quarter. KCG Holdings Inc. now owns 144,501 shares of the company’s stock valued at $460,000 after buying an additional 84,126 shares in the last quarter. UBS Group AG boosted its position in Organovo Holdings by 31.3% in the first quarter. UBS Group AG now owns 1,289,100 shares of the company’s stock valued at $4,099,000 after buying an additional 306,982 shares in the last quarter. Geode Capital Management LLC boosted its position in Organovo Holdings by 44.6% in the first quarter. Geode Capital Management LLC now owns 955,299 shares of the company’s stock valued at $3,037,000 after buying an additional 294,861 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Organovo Holdings by 8.5% in the first quarter. Vanguard Group Inc. now owns 4,250,017 shares of the company’s stock valued at $13,515,000 after buying an additional 333,034 shares in the last quarter. Institutional investors and hedge funds own 22.63% of the company’s stock.

Organovo Holdings Company Profile

Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.